Macrophages in cancer metastases and their relevance to metastatic growth
Author:
- 1 January 1983
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 2 (1) , 75-88
Abstract
The dissemination of malignant cells throughout the body to form secondary growths is a highly complex process dependent upon both host and tumor cell properties. One potential defensive system which could influence the outcome of metastasis is the mononuclear phagocyte system. Although macrophages have been observed in essentially all primary and metastatic tumors examined regardless of histologic type or anatomic location, the biological significance of these observations is far from clear. What is clear, however, is that in most cases the effects of macrophages on tumor cells are not sufficient to alter progressive growth. Therefore, the presence of macrophages within metastases does not necessarily signify a protective host defensive response. On the other hand, macrophage-induced regression of established metastases can occur in vivo under certain conditions in which tumor-bearing mice are treated systemically with macrophage-activating agents. When mice bearing metastases are treated with macrophage-activating agents contained within liposomes, metastasis-associated macrophages are activated to the tumoricidal state and the metastatic lesions are simultaneously eradicated. Such a process of macrophage activation may have implications in determining successful approaches to the therapy of disseminated cancer.Keywords
This publication has 46 references indexed in Scilit:
- Immunohistologic evidence for the role of antibody and macrophages in regression of the murine T1699 mammary adenocarcinomaInternational Journal of Cancer, 1981
- In vitro effects on tumor cells of macrophages isolated from an early‐passage chemically‐induced murine sarcoma and from its spontaneous metastasesInternational Journal of Cancer, 1981
- In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomesCellular Immunology, 1981
- Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene‐induced sarcomasInternational Journal of Cancer, 1980
- Divergent effects of macrophage toxins on growth of primary tumors and lung metastases in miceInternational Journal of Cancer, 1980
- Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumorsInternational Journal of Cancer, 1979
- THE SIGNIFICANCE OF MACROPHAGES IN HUMAN AND EXPERIMENTAL TUMORS*Annals of the New York Academy of Sciences, 1976
- An Inhibitor of Macrophage Chemotaxis Produced by NeoplasmsScience, 1976
- MACROPHAGES IN SYNGENEIC ANIMAL TUMOURSTransplantation, 1972
- Resistance to Murine Tumors Conferred by Chronic Infection with Intracellular Protozoa, Toxoplasma gondii and Besnoitia jellisoniThe Journal of Infectious Diseases, 1971